Mismatching for minor histocompatibility antigens in bone marrow transplantation: consequences for the development and control of severe graft-versus-host disease
Mathé, G.; Pritchard, L.L.; Halle-Pannenko, O.
Transplantation Proceedings 11(1): 235-239
1979
ISSN/ISBN: 0041-1345 PMID: 377638 Document Number: 140660
Document emailed within 1 workday
Related Documents
Cukrová, V.; Dolezalová, L.; Loudová, M.; Vítek, A.; Starý, J. 1997: Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation Casopis Lekaru Ceskych 136(3): 80-84Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
de la Selle, V.; Miconnet, I.; Gilbert, D.; Bruley-Rosset, M. 1995: Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect Bone Marrow Transplantation 16(1): 111-118
Fauser, A.A.; Shustik, C.; Langleben, A.; Laurent, G.; Kanz, L.; Spurll, G.M.; Price, G.; Ahlgren, P.D.; Cooper, B.A. 1988: T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(1): 40-46
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Sakamoto, K.; Sachs, D.H.; Shimada, S.; Popitz-Bergez, F.A.; Pennington, L.R.; Pescovitz, M.D.; McDonough, M.A.; MacVittie, T.J.; Katz, S.I.; Gress, R.E. 1988: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow Transplantation 45(5): 869-875
Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Izzi, T.; Lucarelli, G. 1983: Bone marrow transplantation in humans. IV. the graft versus host disease Recenti Progressi in Medicina 74(6): 720-732
Devergie, A.; Esperou, H.; Traineau, R.; Varrin, F.; Lehn, P.; Gluckman, E. 1989: Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation Nouvelle Revue Francaise d'Hematologie 31(2): 73-75
Slavin, S.; Or, R.; Cividalli, G.; Brautbar, C.; Hale, G.; Waldmann, H.; Rachmilewitz, E. 1988: Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease Birth Defects Original Article Series 23(5b): 313-316
Cooper, M.H.; Hartman, G.G.; Starzl, T.E.; Fung, J.J. 1991: The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506 Transplantation Proceedings 23(6): 3234-3235
Champlin, R. 1992: Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation Seminars in Hematology 29(3 Suppl 2): 46-52
Phillips, G.L.; Nevill, T.J.; Spinelli, J.J.; Nantel, S.H.; Klingemann, H.G.; Barnett, M.J.; Shepherd, J.D.; Chan, K.W.; Meharchand, J.M.; Sutherland, H.J. 1995: Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation Bone Marrow Transplantation 15(2): 213-219
Sullivan, K.M.; Siadak, M.F.; Witherspoon, R.P. 1990: Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation Transplantation Proceedings 22(3): 1336-1338
Johnsen, H.E. 1993: Predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings New England Journal of Medicine 328(20): 1497-1498
Lachance, S.; Le Gouvello, S.; Roudot, F.; Kuentz, M.; Bernaudin, F.; Beaujean, F.; Bierling, P.; Cordonnier, C.; Farcet, J.P.; Vernant, J.P. 1997: Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies Transplantation 64(8): 1147-1152
Blazar, B.R.; Taylor, P.A.; Fitzsimmons, W.E.; Vallera, D.A. 1994: FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation Journal of Immunology 153(4): 1836-1846